Lastly, the CHEK2 gene variant (E239K, rs121908702) was initially identified in men with prostate cancer [51] but has also had conflicting association with cases [52] and controls [53] in two separate breast cancer cohorts. The gene discussed is CHEK2; the disease is prostate carcinoma.